| Literature DB >> 35252832 |
Wenhui Hu1,2, Yun Wang1,2, Jin Chen1,2, Peng Yu1,2, Fuzhou Tang1,2, Zuquan Hu1,2, Jing Zhou1,2, Lina Liu1,2, Wei Qiu1,2, Yuannong Ye1,2, Yi Jia1,2, Shi Zhou3, Jinhua Long4, Zhu Zeng1,2,5,6.
Abstract
The performance of implanted biomaterials is largely determined by their interaction with the host immune system. As a fibrous-like 3D network, fibrin matrix formed at the interfaces of tissue and material, whose effects on dendritic cells (DCs) remain unknown. Here, a bone plates implantation model was developed to evaluate the fibrin matrix deposition and DCs recruitment in vivo. The DCs responses to fibrin matrix were further analyzed by a 2D and 3D fibrin matrix model in vitro. In vivo results indicated that large amount of fibrin matrix deposited on the interface between the tissue and bone plates, where DCs were recruited. Subsequent in vitro testing denoted that DCs underwent significant shape deformation and cytoskeleton reorganization, as well as mechanical property alteration. Furthermore, the immune function of imDCs and mDCs were negatively and positively regulated, respectively. The underlying mechano-immunology coupling mechanisms involved RhoA and CDC42 signaling pathways. These results suggested that fibrin plays a key role in regulating DCs immunological behaviors, providing a valuable immunomodulatory strategy for tissue healing, regeneration and implantation.Entities:
Keywords: Biomaterial implantation; Biomechanics; Dendritic cells; Fibrin; Immunological functions; Mechanobiology
Year: 2022 PMID: 35252832 PMCID: PMC8894278 DOI: 10.1016/j.mtbio.2022.100224
Source DB: PubMed Journal: Mater Today Bio ISSN: 2590-0064
Fig. 1Fibrin matrix deposition and DCs recruitment after implantation. (a) The medical X-rays image of bone plates implanted into tissue near the tibiae of the rat. (b) Immunofluorescent staining for in vivo deposited fibrin matrix: bright-field image, fluorescence staining of nuclei (blue) and fibrin (green), high-magnification image of fibrin matrix (respectively, from left to right). (c) Flow cytometry analysis for rat leukocytes of implantations sites. Cells were labeled by FITC-CD45. (d) Representative scatter image of the OX62+ CD45+DCs groups in CD45+ leukocytes. (e) The ratios of DCs to leukocytes at 24 h, 48 h, 72 h post-implantation. (f) Rheological behavior of fibrin matrix. (g) Immunofluorescent image of fibrin matrix in vivo, scale bar, 20 μm. (h) SEM image of fibrin matrix constructed in vitro, scale bar, 5 μm. (i) Statistical analysis for pore diameters of fibrin matrix in vivo and constructed in vitro. (j) Schematic diagram of the three conditions for DCs during the fibrin matrix deposition. n = 3 biologically independent measurements, mean ± SD, ∗ p < 0.05, ∗∗ p < 0.01.
Fig. 2DCs exhibited featured morphologies in fibrin matrix. (a, b) Representative SEM images of imDCs (a) and mDCs (b) cultured by fibrin matrix at 6 h. (c, d) Representative confocal images of cytoskeleton of imDCs (c) and mDCs (d) cultured in different conditions at 6 h. From left to right are merged images, bright-field images, fluorescence images of F-actin (red) and nuclei (blue), 3D reconstruction of fluorescence images, respectively.
Fig. 3mechanophenotypes characterization. (a–d) Young's moduli of imDCs. Frequency-distribution histogram (a–c) and the statistical analysis (d) of the Young's modulus values of imDCs. (e–h) Young's moduli of mDCs. Frequency-distribution histogram (e–g) and the statistical analysis (h) of the Young's modulus values of mDCs. (i, j) Fluorescence polarizations of imDCs (i) and mDCs (j). (k, l) Osmotic fragilities of imDCs (k) and mDCs (l). n = 3 biologically independent measurements, mean ± SD, ∗ p < 0.05, ∗∗ p < 0.01.
Fig. 4DCs immunophenotypes analysis. (a) Surface molecules changing of imDCs during maturation process. (b–e) Flow cytometer analyses for functional associated surface molecules of imDCs and mDCs. (b) CD80, (c) CD86, (d) HLA-DR, (e) Flow cytometer analyses for CD205 of imDCs. (f) Endocytosis activities of imDCs. The imDCs were taken out from different conditions after culturing in fibrin for 3 h, 6 h and 48 h, respectively. (g–h) Proliferation of T cells was measured by CFSE dilution at 72 h post-activation mDCs treated by 2D and 3D fibrin matrix for 6 h, mDCs-S served as control. (g) Representative CFSE dilution from a single experiment. (i, j) ELISA analyses for IL-12 (i) and IL-18 (j) of mDCs supernatants at 3 h and 6 h treated by 2D and 3D fibrin matrix. Values represent the mean ± SD, n = 3 biologically independent measurements, ∗p < 0.05, ∗∗p < 0.01.
Fig. 5RhoA and CDC42 signaling pathways involved in DCs mechano-immunological coupling mechanisms. (a) Representative confocal images of cytoskeleton and RhoA of DCs collected from different conditions at 6 h. From left to right are fluorescence images of F-actin (red), RhoA (green), nuclei (blue), merged fluorescence images and corresponding fluorescence intensity profiles across yellow lines, respectively. (b) Representative confocal images of cytoskeleton and CDC42 of DCs collected from different conditions at 6 h. From left to right are fluorescence images of F-actin (red), CDC42 (green), nuclei (blue) and merged fluorescence images, respectively. (c) Mean fluorescence intensity of RhoA of imDCs. (d) The normalized mean fluorescence intensity ratio of imDCs nucleus regions to cell body regions. (e) mean fluorescence intensity of RhoA of mDCs. (f) The normalized mean fluorescence intensity ratio of mDCs nucleus regions to cell body regions. (g, h) mean fluorescence intensity of CDC42 of imDCs (g) and mDCs (h). (i, j) RT-qPCR analysis for mRNA expressions of imDCs (i) and mDCs (j). Values represent the mean ± SD, n = 3 biologically independent measurements, ∗p < 0.05, ∗∗p < 0.01.